NM_018975.4:c.38G>A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018975.4(TERF2IP):c.38G>A(p.Gly13Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,458,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. G13G) has been classified as Likely benign.
Frequency
Consequence
NM_018975.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 89Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
- leukoencephalopathy, progressive, infantile-onset, with or without deafnessInheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth disease recessive intermediate BInheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nonsyndromic genetic hearing lossInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERF2IP | NM_018975.4 | c.38G>A | p.Gly13Glu | missense_variant | Exon 1 of 3 | ENST00000300086.5 | NP_061848.2 | |
TERF2IP | XM_047434216.1 | c.38G>A | p.Gly13Glu | missense_variant | Exon 1 of 2 | XP_047290172.1 | ||
TERF2IP | NR_144545.2 | n.148G>A | non_coding_transcript_exon_variant | Exon 1 of 3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TERF2IP | ENST00000300086.5 | c.38G>A | p.Gly13Glu | missense_variant | Exon 1 of 3 | 1 | NM_018975.4 | ENSP00000300086.4 | ||
KARS1 | ENST00000566560.5 | n.176+548C>T | intron_variant | Intron 1 of 6 | 1 | |||||
TERF2IP | ENST00000653858.1 | c.38G>A | p.Gly13Glu | missense_variant | Exon 1 of 4 | ENSP00000499565.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1458764Hom.: 0 Cov.: 31 AF XY: 0.00000276 AC XY: 2AN XY: 725098 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.G13E variant (also known as c.38G>A), located in coding exon 1 of the TERF2IP gene, results from a G to A substitution at nucleotide position 38. The glycine at codon 13 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at